pirfenidone has been researched along with Proteinuria in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, K; Iwai, N; Ji, X; Kito, N; Li, J; Ma, X; Naito, Y; Weng, H; Yanagawa, N; Yu, Y | 1 |
| Mitori, H; Mizukami, K; Noto, T; Takakura, K; Tomura, Y | 1 |
| Chikanishi, T; Fujimori, A; Itoh, H; Iwatsuki, Y; Nakajima, H; Okada, M; Takakuta, K; Tanokura, A; Yamamoto, M | 1 |
| Chen, JF; Liu, BC; Liu, H; Ni, HF; Pan, MM; Xu, M; Zhang, MH | 1 |
| Bao, L; Cho, IH; Hyun, BH; Kim, YJ; Lee, CH; Margolin, SB; Park, HS; Park, YH | 1 |
| Cohen, EP; Fish, BL; Moulder, JE; Raife, TJ; Regner, KR | 1 |
6 other study(ies) available for pirfenidone and Proteinuria
| Article | Year |
|---|---|
Renoprotective mechanisms of pirfenidone in hypertension-induced renal injury: through anti-fibrotic and anti-oxidative stress pathways.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Catalase; Fibrosis; Gene Expression Regulation; Hypertension, Renal; Kidney; Male; Matrix Metalloproteinase 9; Oxidative Stress; Proteinuria; Pyridones; Rats; Rats, Inbred Dahl; Signal Transduction; Smad2 Protein; Smad3 Protein; Sodium Chloride, Dietary; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2013 |
Antiproteinuric effect of pirfenidone in a rat model of anti-glomerular basement membrane glomerulonephritis.
Topics: Animals; Chemokine CCL2; Creatinine; Disease Models, Animal; Gene Expression Regulation; Glomerular Basement Membrane; Glomerulonephritis; Male; Proteinuria; Pyridones; Rats; RNA, Messenger | 2014 |
Renoprotective properties of pirfenidone in subtotally nephrectomized rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Differentiation; Cell Line; Chronic Disease; Disease Progression; Enalapril; Epithelial Cells; Fibrosis; Kidney; Kidney Failure, Chronic; Male; Mesoderm; Nephrectomy; Proteinuria; Pyridones; Rats; Rats, Wistar; Transforming Growth Factor beta | 2010 |
Pirfenidone inhibits macrophage infiltration in 5/6 nephrectomized rats.
Topics: Acetylglucosaminidase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Blood Pressure; Chemokine CCL2; Chemokine CCL3; Drug Evaluation, Preclinical; Kidney; Macrophages; Male; Nephrectomy; Nephrosclerosis; Phenotype; Proteinuria; Pyridones; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic | 2013 |
Pirfenidone suppressed the development of glomerulosclerosis in the FGS/Kist mouse.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Disease Models, Animal; Female; Fibrosis; Glomerular Filtration Rate; Glomerulonephritis; Kidney; Kidney Diseases; Male; Mice; Proteinuria; Pyridones; Sclerosis; Time Factors | 2003 |
Retinoic acid exacerbates experimental radiation nephropathy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Division; Extracellular Matrix; Fibrosis; Hypertension, Renal; Kidney; Kidney Diseases; Kidney Failure, Chronic; Proteinuria; Pyridones; Radiation Injuries, Experimental; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidines; Tretinoin; Uremia; Whole-Body Irradiation | 2002 |